MAPT and Alzheimer disease: The interactomes of amyloid beta and hyperphosphorylated tau proteins differ significantly in rpAD from those in slowly progressive cases [13,14]; however, the pathogenetic mechanism of distinct progression rates in AD is not understood [15–18].